Ibrutinib
Category: CancerIbrutinib Overview
Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells. It is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.[3] Contents 1 Medical uses 1.1 Resistance 2 Adverse effects 3 Pharmacology 3.1 Mechanism 4 History 5 Cost 6 Brand names 7 References 8 External links ...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ibrutinib
Recent Ibrutinib Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Ibrutinib
- Capsule: 140 Mg., 140mg, 70mg
- Tablet: 140mg, 280mg, 420mg, 560mg
Other drugs which contain Ibrutinib or a similar ingredient: (1 result)
- IMBRUVICA Ibrutinib2 discussions